Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beran

Showing results (201-210 of 251) with videos related to

Pageof 26
Sort By:
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabineH M Kantarjian, M J Keating, E H Estey, et al.
Cancer|August 15, 1988
Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinosideH M Kantarjian, R S Walters, M J Keating, et al.
Leukemia Research|July 21, 1998
Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemiaZ Estrov, M Talpaz, S Ku, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaN Vey, H Kantarjian, H Tran, et al.
Leukemia|March 1, 1997
Decitabine studies in chronic and acute myelogenous leukemiaH M Kantarjian, S M O'Brien, E Estey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)M Beran, X Cao, Z Estrov, et al.
Pageof 26

Showing results (201-210 of 251) with videos related to

Sort By:
Pageof 26
Blood|August 8, 1998
Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapyM J Keating, S O'Brien, S Lerner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemiaH M Kantarjian, M J Keating, K B McCredie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, T L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabineH M Kantarjian, M J Keating, E H Estey, et al.
Cancer|August 15, 1988
Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinosideH M Kantarjian, R S Walters, M J Keating, et al.
Leukemia Research|July 21, 1998
Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemiaZ Estrov, M Talpaz, S Ku, et al.
Leukemia|October 27, 1997
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemiaS Sacchi, H M Kantarjian, S O'Brien, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemiaN Vey, H Kantarjian, H Tran, et al.
Leukemia|March 1, 1997
Decitabine studies in chronic and acute myelogenous leukemiaH M Kantarjian, S M O'Brien, E Estey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)M Beran, X Cao, Z Estrov, et al.
Pageof 26